ID

33517

Beskrivning

Study ID: 104297 Clinical Study ID: 104297 Study Title: An open study for a 2-year period to confirm the safety and immunogenicity of the candidate malaria vaccine RTS,S/AS02A in Mozambican children aged 1 to 4 years at the time of first vaccine dose. Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00323622 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 2 Study Recruitment Status: Completed Generic Name: SB257049 Trade Name: SB257049 Study Indication: Malaria

Nyckelord

  1. 2018-12-11 2018-12-11 -
  2. 2019-06-05 2019-06-05 -
  3. 2019-06-06 2019-06-06 - Sarah Riepenhausen
Rättsinnehavare

GSK group of companies

Uppladdad den

11 december 2018

DOI

För en begäran logga in.

Licens

Creative Commons BY-NC 3.0

Modellkommentarer :

Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.

Itemgroup-kommentar för :

Item-kommentar för :

Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.

Immunogenicity of malaria vaccine candidate in Mozambican children (1 to 4 y.o) - 104297 (Malaria039)

Visit 1: Eligibility Criteria

Administrative data
Beskrivning

Administrative data

Protocol Number
Beskrivning

Protocol Number

Datatyp

integer

Subject Number
Beskrivning

Subject Number

Datatyp

integer

Visit
Beskrivning

Visit

Datatyp

text

Eligibility Check
Beskrivning

Eligibility Check

Did the subject meet all the entry criteria?
Beskrivning

entry criteria met?

Datatyp

boolean

If No, tick all boxes corresponding to violations of any inclusion/exclusion criteria.
Beskrivning

If No, tick all boxes corresponding to violations of any inclusion/exclusion criteria.

Datatyp

text

Inclusion Criteria
Beskrivning

Inclusion Criteria

Tick all the boxes corresponding to any of the inclusion criteria the subject failed.
Beskrivning

Tick all the boxes corresponding to any of the inclusion criteria the subject failed.

Datatyp

integer

Exclusion Criteria
Beskrivning

Exclusion Criteria

Tick all the boxes corresponding to any of the exclusion criteria that disqualified the subject from entry.
Beskrivning

Tick all the boxes corresponding to any of the exclusion criteria that disqualified the subject from entry.

Datatyp

text

Similar models

Visit 1: Eligibility Criteria

Name
Typ
Description | Question | Decode (Coded Value)
Datatyp
Alias
Item Group
Administrative data
Protocol Number
Item
Protocol Number
integer
Subject Number
Item
Subject Number
integer
Item
Visit
text
Code List
Visit
CL Item
Visit 1, Study month 21 (21 months post dose 1 in Malaria-026) (1)
Item Group
Eligibility Check
entry criteria met?
Item
Did the subject meet all the entry criteria?
boolean
If No, tick all boxes corresponding to violations of any inclusion/exclusion criteria.
Item
If No, tick all boxes corresponding to violations of any inclusion/exclusion criteria.
text
Item Group
Inclusion Criteria
Item
Tick all the boxes corresponding to any of the inclusion criteria the subject failed.
integer
Code List
Tick all the boxes corresponding to any of the inclusion criteria the subject failed.
CL Item
Completion of Visit 7, Month 21 of Malaria-026. (1)
CL Item
Written informed consent obtained from the parent(s) or guardian(s) of the subject. (2)
Item Group
Exclusion Criteria
Item
Tick all the boxes corresponding to any of the exclusion criteria that disqualified the subject from entry.
text
Code List
Tick all the boxes corresponding to any of the exclusion criteria that disqualified the subject from entry.
CL Item
Planned use of any investigational or non-registered drug or vaccine during the study period. (1)
CL Item
Simultaneous participation in any other clinical trial. (2)

Använd detta formulär för feedback, frågor och förslag på förbättringar.

Fält markerade med * är obligatoriska.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial